- Ann Bell, Principal Investigator
- Steven S. Martin, Co-Investigator
J. O’Connell, Senior Data Analyst
- Sofia Gonzalez, Field Coordinator
- David Borton, Data Analyst
- Katherine Kafonek, Graduate Research Assistant
2016; Funding Source: University of Maryland (subcontract) through private
Access Now (Del-CAN), a public/private partnership between Upstream USA and the
Delaware Division of Public Health, aims to reduce the state’s unintended
pregnancy rate by increasing access to the full range of contraceptive methods,
including the most effective IUDs and implants, for all women in Delaware.
Upstream USA is providing training, technical assistance, and quality
improvement support to large private health care providers and all publicly-funded
health care providers in the state.
Researchers at the
University of Maryland, College Park (UMD) have partnered with colleagues at
the University of Delaware, Newark (UD), and with key Delaware stakeholders, on
a systematic, mixed-methods evaluation of Del-CAN which aims to (1) reduce
unintended pregnancies, (2) reduce Medicaid costs for unintended pregnancies,
and (3) support policy development that enables contraceptive access to all
women who desire it. The evaluation, led by Dr. Michael Rendall, Professor and
Director of the Maryland Population Research Center, is designed to understand
the Del-CAN’s effectiveness and cost-effectiveness, and to derive lessons about
mechanisms leading to initial and sustained impacts in Delaware, and to impacts
that are generalizable to other states.
As part of this 5-year evaluation, professor Ann Bell is leading a team to conduct qualitative interviews of women, their partners, and providers. CHDS is conducting a survey of Title X
clinic family planning users, secondary analysis of data from teenagers completing
the Delaware Youth Risk Behavioral
Surveillance Survey, and a survey of primary care providers.